Digital Stethoscope Detects Heart Disease

Rethinking the Role of the Stethoscope

Heart disease remains one of the world’s most pressing health challenges, and many cases are missed in their earliest stages. Eko Health steps into this gap with digital stethoscopes that integrate FDA-cleared AI detection. These devices enable doctors to pick up murmurs, atrial fibrillation, and low ejection fraction during routine visits—conditions often overlooked when relying only on traditional listening.

By moving beyond the limitations of analog tools, Eko Health provides both sound and sight. Each exam captures high-quality audio and displays real-time waveforms or single-lead ECGs, giving clinicians an additional layer of precision. This dual approach makes everyday auscultation more measurable, more consistent, and easier to share across care teams.

What This Technology Brings to the Exam Room

Eko Health blends essential features into one tool that fits smoothly into clinical practice. Digital noise cancellation ensures clarity even in busy environments, while visual data confirms what the ear detects. The AI engine runs in real time, signaling patterns linked to heart disease without interrupting workflow. Recordings can be stored, compared across visits, or used in telehealth consultations, ensuring continuity of care. Together, these features transform a routine checkup into a stronger safeguard against hidden conditions.

Adoption and Validation in Practice

• Widespread use: More than 600,000 clinicians rely on Eko Health tools in their daily work.

• Regulatory trust: Nine FDA clearances confirm the reliability and safety of the technology.

• Research support: Over 50 peer-reviewed studies validate its accuracy and clinical value.

• Improved outcomes: Primary care doctors using Eko are nearly twice as likely to detect heart disease.

• Scalable systems: Integration into hospitals and telehealth platforms shows it works across different care models.

Expanding Access Through Remote Monitoring

Beyond individual patients, Eko Health’s impact is visible in wider healthcare systems. Research shows that clinicians using these devices are almost twice as likely to detect cardiovascular disease in primary care. With more than 600,000 users and multiple FDA approvals, the technology is already trusted in hospitals and clinics worldwide. Its telehealth compatibility further broadens reach, allowing patients in underserved areas to benefit from accurate monitoring without traveling to specialists. In the long term, standardized digital listening could become a foundation for equitable access to heart and lung care.